1.
Major A, Kline J, Karrison TG, Fishkin PAS, Kimball AS, Petrich AM, Nattam S, Rao K, Sleckman BG, Cohen K, Besien K van, Rapoport AP, Smith SM. Phase I/II clinical trial of temsirolimus and lenalidomide in patients with relapsed and refractory lymphomas. haematol [Internet]. 2022Jul.1 [cited 2024Mar.29];107(7):1608-1. Available from: https://haematologica.org/article/view/haematol.2021.278853